Biotech

GeoVax Labs announced their chief scientific officer, Dr. Farshad Guirakhoo presented the company’s results in its studies of their NS-1 based Zika vaccine.

GeoVax Labs (OTCQB:GOVX) announced their chief scientific officer, Dr. Farshad Guirakhoo presented the company’s results in its studies of their NS-1 based Zika vaccine.
As quoted in the press release:

Dr. Guirakhoo delivered the talk, entitled “A Novel Alternative Approach to Develop a Safe Vaccine for Zika,” today during the Advances in Vaccine Technologies session at the Immuno-Oncology Summit in Boston, MA.
Dr. Guirakhoo presented research showing that a single dose of GeoVax’s Zika vaccine gave 100% protection in normal mice challenged with a lethal dose of Zika virus (ZIKV) delivered directly into the brain. This is the first report of i) a Zika vaccine based on the ZIKV NS1 protein, and ii) single-dose full protection against ZIKV using an immunocompetent lethal mouse challenge model.

Click here to read the full press release.

Source: www.marketwired.com

MARKETS

Markets
TSX18729.66-104.50
TSXV602.35-13.59
DOW31037.68+69.86
S&P 5003845.08+13.69
NASD11361.85+39.61
ASX6594.50-34.80

COMMODITIES

Commodities
Gold1744.78+4.38
Silver19.36+0.17
Copper3.49+0.08
Palladium1930.50+14.50
Platinum864.00+8.00
Oil99.00+0.47
Heating Oil3.46+0.05
Natural Gas5.56+0.05

DOWNLOAD FREE REPORTS

×